• Mingyuan Wu, Naoka Komori, Chao Qin, Jay P Farber, Bengt Linderoth, and Robert D Foreman.
• Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA.
• Brain Res. 2008 May 1; 1207: 73-83.

Background And AimsSCS is used to improve peripheral circulation in selected patients with ischemia of the extremities. However the mechanisms are not fully understood. The present study investigated whether blockade of ERK and AKT activation modulated SCS-induced vasodilation.MethodsA unipolar ball electrode was placed on the left dorsal column at the lumbar 2-3 spinal segments in rats. Cutaneous blood flows from left and right hind foot pads were recorded with laser Doppler flow perfusion monitors. SCS was applied through a ball electrode at 60% or 90% of MT. U0126, an inhibitor of ERK kinase, or LY294002, an inhibitor of PI3K upstream of AKT, was applied to the lumbar 3-5 spinal segments (n=7, each group).ResultsU0126 (100 nM, 5 microM and 250 microM) significantly attenuated SCS-induced vasodilation at 60% (100 nM: P<0.05; 5 microM and 250 microM: P<0.01, respectively) and 90% of MT (100 nM and 5 microM: P<0.05; 250 microM: P<0.01, respectively). LY294002 at 100 microM also attenuated SCS-induced vasodilation at 60% and 90% of MT (P<0.05).ConclusionsThese data suggest that ERK and AKT pathways are involved in SCS-induced vasodilation.

46 keywords...

hide…